117 related articles for article (PubMed ID: 36841028)
1. Niclosamide causes lysosome-dependent cell death in endometrial cancer cells and tumors.
Rai R; Dey DK; Benbrook DM; Chandra V
Biomed Pharmacother; 2023 May; 161():114422. PubMed ID: 36841028
[TBL] [Abstract][Full Text] [Related]
2. A Novel High Content Imaging-Based Screen Identifies the Anti-Helminthic Niclosamide as an Inhibitor of Lysosome Anterograde Trafficking and Prostate Cancer Cell Invasion.
Circu ML; Dykes SS; Carroll J; Kelly K; Galiano F; Greer A; Cardelli J; El-Osta H
PLoS One; 2016; 11(1):e0146931. PubMed ID: 26784896
[TBL] [Abstract][Full Text] [Related]
3. Metformin inhibits proliferation and migration of endometrial cancer cells through regulating PI3K/AKT/MDM2 pathway.
Qiang P; Shao Y; Sun YP; Zhang J; Chen LJ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1778-1785. PubMed ID: 30840303
[TBL] [Abstract][Full Text] [Related]
4. Knocking down FAM83B inhibits endometrial cancer cell proliferation and metastasis by silencing the PI3K/AKT/mTOR pathway.
Lin Q; Chen H; Zhang M; Xiong H; Jiang Q
Biomed Pharmacother; 2019 Jul; 115():108939. PubMed ID: 31079003
[TBL] [Abstract][Full Text] [Related]
5. Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway.
Lin L; Gao Y; Hu X; Ouyang J; Liu C
BMC Womens Health; 2022 Nov; 22(1):470. PubMed ID: 36434592
[TBL] [Abstract][Full Text] [Related]
6. miR-205 inhibits cell growth by targeting AKT-mTOR signaling in progesterone-resistant endometrial cancer Ishikawa cells.
Zhuo Z; Yu H
Oncotarget; 2017 Apr; 8(17):28042-28051. PubMed ID: 28427207
[TBL] [Abstract][Full Text] [Related]
7. Suppression of PI3K/Akt/mTOR/c-Myc/mtp53 Positive Feedback Loop Induces Cell Cycle Arrest by Dual PI3K/mTOR Inhibitor PQR309 in Endometrial Cancer Cell Lines.
Hsin IL; Shen HP; Chang HY; Ko JL; Wang PH
Cells; 2021 Oct; 10(11):. PubMed ID: 34831139
[TBL] [Abstract][Full Text] [Related]
8. Repurposing Niclosamide for Targeting Pancreatic Cancer by Inhibiting Hh/Gli Non-Canonical Axis of Gsk3β.
Kaushal JB; Bhatia R; Kanchan RK; Raut P; Mallapragada S; Ly QP; Batra SK; Rachagani S
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34206370
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of lncRNA CCAT2 inhibits endometrial cancer cells growth and metastasis via sponging miR-216b.
Xie P; Cao H; Li Y; Wang J; Cui Z
Cancer Biomark; 2017 Dec; 21(1):123-133. PubMed ID: 29036788
[TBL] [Abstract][Full Text] [Related]
10. [Effects of PD98059 and LY294002 on subcutaneous xenograft of human endometrial carcinoma in nude mice].
Guo RX; Zhang RF; Wang XY; Shi HR; Qiao YH
Zhonghua Fu Chan Ke Za Zhi; 2011 Jun; 46(6):446-52. PubMed ID: 21781587
[TBL] [Abstract][Full Text] [Related]
11. Fucoxanthin prevents cell growth and induces apoptosis in endometrial cancer HEC-1A cells by the inhibition of the PI3K/Akt/mTOR pathway.
Qu J; Sun Y; Yang L; Niu X; Li L
J Biochem Mol Toxicol; 2022 Jun; 36(6):e23027. PubMed ID: 35266250
[TBL] [Abstract][Full Text] [Related]
12. Injectable pegylated niclosamide (polyethylene glycol-modified niclosamide) for cancer therapy.
Ma R; Ma ZG; Gao JL; Tai Y; Li LJ; Zhu HB; Li L; Dong DL; Sun ZJ
J Biomed Mater Res A; 2020 Jan; 108(1):30-38. PubMed ID: 31433913
[TBL] [Abstract][Full Text] [Related]
13. Repurposing of the anti-helminthic drug niclosamide to treat melanoma and pulmonary metastasis via the STAT3 signaling pathway.
Zhu Y; Zuo W; Chen L; Bian S; Jing J; Gan C; Wu X; Liu H; Su X; Hu W; Guo Y; Wang Y; Ye T
Biochem Pharmacol; 2019 Nov; 169():113610. PubMed ID: 31465777
[TBL] [Abstract][Full Text] [Related]
14. Vitexin suppresses the proliferation, angiogenesis and stemness of endometrial cancer through the PI3K/AKT pathway.
Liang C; Jiang Y; Sun L
Pharm Biol; 2023 Dec; 61(1):581-589. PubMed ID: 36994813
[TBL] [Abstract][Full Text] [Related]
15. Antihelminthic Niclosamide Induces Autophagy and Delayed Apoptosis in Human Non-small Lung Cancer Cells
Chai WH; Li YR; Lin SH; Chao YH; Chen CH; Chan PC; Lin CH
Anticancer Res; 2020 Mar; 40(3):1405-1417. PubMed ID: 32132037
[TBL] [Abstract][Full Text] [Related]
16. The antitumor effect of lobaplatin against Ishikawa endometrial cancer cells in vitro and in vivo.
He J; Zhang H
Biomed Pharmacother; 2019 Jun; 114():108762. PubMed ID: 30925454
[TBL] [Abstract][Full Text] [Related]
17. MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTOR.
Zhang S; Wang M; Li Q; Zhu P
Cancer Biomark; 2017 Dec; 21(1):179-186. PubMed ID: 29081412
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of Trop2 inhibits proliferation and migration and induces apoptosis of endometrial cancer cells via AKT/β-catenin pathway.
Sun X; Xing G; Zhang C; Lu K; Wang Y; He X
Cell Biochem Funct; 2020 Mar; 38(2):141-148. PubMed ID: 31967350
[TBL] [Abstract][Full Text] [Related]
19. The Glutaminase Inhibitor Compound 968 Exhibits Potent
Guo H; Li W; Pan G; Wang C; Li D; Liu N; Sheng X; Yuan L
Anticancer Agents Med Chem; 2023; 23(2):210-221. PubMed ID: 35570522
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effect of XCT790, an ERRα inverse agonist, on ERα-negative endometrial cancer cells.
Kokabu T; Mori T; Matsushima H; Yoriki K; Kataoka H; Tarumi Y; Kitawaki J
Cell Oncol (Dordr); 2019 Apr; 42(2):223-235. PubMed ID: 30706380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
